Hypocomplementemia in systemic sclerosis;L'ipocomplementemia nella sclerosi sistemica

Reumatismo

Volumn 60, Issue 4, 2008, Pages 268-273

  Cuomo, Giovanni ^a   Abignano, G ^a   Ruocco, L ^a   Vettori, S ^a   Valentini, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Activity index; Hypocomplementemia; Systemic sclerosis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GENDER; HOSPITAL ADMISSION; HUMAN; HYPOCOMPLEMENTEMIA; ITALY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; SEROLOGY; SKIN DISEASE; SYSTEMIC SCLEROSIS; UNIVERSITY HOSPITAL; VASCULAR DISEASE;

ADULT; AGED; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 65449188653     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Seibold J. Scleroderma. In: Harris E, Budd RC, Firestein GS, et al, editors. Kelley's textbook of Rheumatology. 7th ed. Philadelphia: Elsevier; 2005.
2. Wigley FM, Hummers LK. Clinical features of systemic sclerosis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt MF, Weisman MH eds. Rheumatology, 3rd ed. Elsevier, 2006.
3. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117:557-67.
4. Gerber MA. Immunohistochemical findings in the renal vascular lesions of progressive systemic sclerosis. Hum Pathol 1975; 6: 343-7.
5. Evans DJ, Cashman SJ, Walport M. Progressive systemic sclerosis: autoimmune arteriopathy. Lancet 1987; 1: 480-2.
6. Senaldi G, Lupoli S, Vergani D, Black CN. Activation of the complement system in systemic sclerosis. Relationship to clinical severity. Arthritis Rheum 1989; 32: 1262-7.
7. Townes AS. Topics in clinical medicine. Complement's levels in disease. Johns Hopkins Med J 1967; 120: 337-9.
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
9. Valentini G, Della Rossa A, Bombardieri S, Bencivelli-W, Silman AJ, D'Angelo S et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 60: 592-8.
10. Hudson M, Walker JG, Fritzler M, Taillefer S, Canadian Scleroderma Research Group, Baron M. Hypocomplementemia in Systemic sclerosis, Clinical and serological correlations. J Rheumatol 2007; 34: 1-6.
11. Hudson M, Steele R; Canadian Scleroderma Research Group (CSRG), Baron M. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 2007; 37: 93-8.
12. Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheum 2003; 29: S47-49.
13. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA jr, et al. Scleroderma (Systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988; 15: 9202-5.
14. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing: J Rheumatol 1999; 26: 2159-67.
15. La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G. HAQ-DI Italian version in systemic sclerosis. Reumatismo 2006; 58: 112-5.
16. Della Rossa A, Valentini G, Bombardieri S, et al. European multicentre study to define disease activity for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001; 60: 585-91
17. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-6.
18. American Rheumatism Association Glossary Committee. Dictionary of the rheumatic disease. Vol 1, New York, Contact Associates, 1982.
19. Della Rossa A, Valentini G, Bombardieri S, et al. European multicentre study to define disease activity for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001; 60: 585-91
20. Owens GR, Fino CJ, Herbert DL, et al. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983; 84: 546-50.
21. American Rheumatism Association Glossary Committee. Dictionary of the rheumatic disease. Vol II, New York, Contact Associates, 1982.